Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 18/04/2025 |
clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 18/04/2025 |
gabapentin | Capsule, hard | 300 mg | Current | Limited Availability | Manufacturing | 17/04/2025 |
zolpidem tartrate | Tablet, film coated | 10 mg | Resolved | Available | Manufacturing | 17/04/2025 |
midazolam | Injection, solution | 5 mg/mL | Anticipated | Available | Manufacturing | 17/04/2025 |
venlafaxine | Capsule, modified release | 75 mg | Current | Limited Availability | Manufacturing | 17/04/2025 |
venlafaxine | Capsule, modified release | 150 mg | Current | Limited Availability | Manufacturing | 17/04/2025 |
clomipramine hydrochloride | Tablet, film coated | 25 mg | Resolved | Available | Manufacturing | 17/04/2025 |
losartan potassium | Tablet, film coated | 50 mg | Current | Limited Availability | Manufacturing | 17/04/2025 |
losartan potassium | Tablet, film coated | 25 mg | Current | Limited Availability | Manufacturing | 17/04/2025 |
mirtazapine | Tablet, film coated | 45 mg | Current | Unavailable | Manufacturing | 17/04/2025 |
donepezil hydrochloride | Tablet, film coated | 10 mg | Current | Unavailable | Manufacturing | 17/04/2025 |
rocuronium bromide | Injection, solution | 50 mg | Anticipated | Available | Manufacturing | 17/04/2025 |
pramipexole dihydrochloride monohydrate | Tablet | 1 mg | Current | Unavailable | Manufacturing | 17/04/2025 |
pramipexole dihydrochloride monohydrate | Tablet | .25 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 17/04/2025 |
amlodipine besilate~olmesartan medoxomil~hydrochlorothiazide | Tablet | 6.944 mg~40 mg~12.5 mg | Current | Limited Availability | Manufacturing | 17/04/2025 |
ezetimibe~rosuvastatin calcium | Tablet~Tablet, film coated | 10 mg~41.583 mg | Current | Limited Availability | Manufacturing | 17/04/2025 |
ezetimibe~rosuvastatin calcium | Tablet~Tablet, film coated | 10 mg~10.396 mg | Current | Unavailable | Manufacturing | 17/04/2025 |
metoprolol succinate | Tablet, modified release | 95 mg | Current | Limited Availability | Manufacturing | 17/04/2025 |
metoprolol succinate | Tablet, modified release | 47.5 mg | Current | Unavailable | Manufacturing | 17/04/2025 |
metoprolol succinate | Tablet, modified release | 190 mg | Current | Unavailable | Manufacturing | 17/04/2025 |
metoprolol succinate | Tablet, modified release | 23.75 mg | Current | Limited Availability | Manufacturing | 17/04/2025 |
capecitabine | Tablet, film coated | 500 mg | Current | Limited Availability | Unexpected increase in consumer demand | 17/04/2025 |
ezetimibe~atorvastatin calcium trihydrate | Tablet, multilayer | 10 mg~86.8 mg | Current | Limited Availability | Manufacturing | 17/04/2025 |
esomeprazole | Capsule, enteric | 20 mg | Current | Limited Availability | Manufacturing | 17/04/2025 |
anastrozole | Tablet, film coated | 1 mg | Current | Unavailable | Manufacturing | 17/04/2025 |
atorvastatin calcium trihydrate | Tablet, film coated | 43.376 mg | Current | Unavailable | Manufacturing | 17/04/2025 |
spironolactone | Tablet, uncoated | 25 mg | Current | Limited Availability | Manufacturing | 17/04/2025 |
piroxicam | Capsule, hard | 10 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 17/04/2025 |
piroxicam | Capsule, hard | 20 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 17/04/2025 |
spironolactone | Tablet, film coated | 100 mg | Anticipated | Available | Manufacturing | 17/04/2025 |
iopromide | Injection, solution | 498.72 mg/mL | Current | Unavailable | Manufacturing | 17/04/2025 |
reboxetine mesilate | Tablet, uncoated | 5.224 mg | Anticipated | Available | Manufacturing | 17/04/2025 |
primidone | Tablet, uncoated | 250 mg | Current | Unavailable | Manufacturing | 16/04/2025 |
olanzapine | Tablet, film coated | 7.5 mg | Resolved | Available | Manufacturing | 16/04/2025 |
clonidine hydrochloride | Tablet, uncoated | 100 microgram | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 16/04/2025 |
risperidone | Tablet, film coated | 1 mg | Current | Limited Availability | Unexpected increase in consumer demand | 16/04/2025 |
risperidone | Tablet, film coated | .5 mg | Current | Limited Availability | Manufacturing | 16/04/2025 |
duloxetine hydrochloride | Capsule, enteric | 67.3 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 16/04/2025 |
pramipexole dihydrochloride monohydrate | Tablet | .25 mg | Anticipated | Available | Unexpected increase in consumer demand | 16/04/2025 |
fenofibrate | Tablet | 48 mg | Resolved | Available | Manufacturing | 16/04/2025 |
betahistine dihydrochloride | Tablet | 16 mg | Current | Unavailable | Manufacturing | 16/04/2025 |
clonidine hydrochloride | Tablet | 100 microgram | Resolved | Available | Manufacturing | 16/04/2025 |
anastrozole | Tablet, film coated | 1 mg | Current | Limited Availability | Manufacturing | 16/04/2025 |
mercaptopurine monohydrate | Tablet | 50 mg | Anticipated | Available | Manufacturing | 16/04/2025 |
dexmedetomidine hydrochloride | Injection, concentrated | 118 microgram/mL | Anticipated | Available | Manufacturing | 16/04/2025 |
Semaglutide | Injection, solution | 1.34 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 16/04/2025 |
naloxone hydrochloride dihydrate | Spray, nasal | 2.2 mg/actuation | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 16/04/2025 |
nebivolol hydrochloride | Tablet | 10.9 mg | Resolved | Available | Manufacturing | 16/04/2025 |
Semaglutide | Injection, solution | 1.34 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 16/04/2025 |
bortezomib | Injection, solution | 3.5 mg | Anticipated | Available | Manufacturing | 16/04/2025 |
melatonin | Capsule, hard | 3 mg | Current | Unavailable | Unexpected increase in consumer demand | 16/04/2025 |
carbidopa monohydrate~levodopa | Tablet, uncoated | 26.9 mg~100 mg | Current | Limited Availability | Manufacturing | 16/04/2025 |
balsalazide sodium | Capsule | 750 mg | Current | Limited Availability | Manufacturing | 16/04/2025 |
clonidine hydrochloride | Tablet, uncoated | 150 microgram | Resolved | Available | Unexpected increase in consumer demand | 16/04/2025 |
methylphenidate hydrochloride | Tablet, uncoated | 10 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 15/04/2025 |
methylphenidate hydrochloride | Tablet, uncoated | 10 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 15/04/2025 |
adrenaline (epinephrine) acid tartrate | Injection, solution | 1.82 mg/mL | Current | Unavailable | Manufacturing | 15/04/2025 |
amlodipine besilate | Tablet, uncoated | 7 mg | Resolved | Available | Manufacturing | 15/04/2025 |
Hepatitis a virus antigen~Hepatitis B surface antigen recombinant | Injection, suspension | 720 ELISA unit/mL~20 microgram/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 15/04/2025 |
risedronate sodium | Tablet, film coated | 35 mg | Resolved | Available | Manufacturing | 15/04/2025 |
azithromycin dihydrate | Tablet, film coated | 524.1 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 15/04/2025 |
clopidogrel hydrogen sulfate | Tablet, film coated | 97.9 mg | Anticipated | Available | Manufacturing | 15/04/2025 |
propranolol hydrochloride | Tablet, film coated | 40 mg | Current | Limited Availability | Manufacturing | 15/04/2025 |
perindopril erbumine | Tablet | 8 mg | Anticipated | Available | Manufacturing | 15/04/2025 |
sildenafil citrate | Tablet, film coated | 28.1 mg | Current | Limited Availability | Manufacturing | 15/04/2025 |
azithromycin dihydrate | Tablet, film coated | 524 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 15/04/2025 |
hydromorphone hydrochloride | Injection, solution | 2 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 15/04/2025 |
ivabradine hydrochloride | Tablet, film coated | 8.085 mg | Current | Limited Availability | Manufacturing | 15/04/2025 |
acamprosate calcium | Tablet, enteric coated | 333 mg | Current | Limited Availability | Manufacturing | 15/04/2025 |
fluconazole | Capsule, hard | 200 mg | Resolved | Available | Manufacturing | 15/04/2025 |
ropinirole hydrochloride | Tablet, film coated | .57 mg | Current | Limited Availability | Manufacturing | 15/04/2025 |
Pegfilgrastim | Injection, solution | 6 mg | Current | Limited Availability | Manufacturing | 15/04/2025 |
tamoxifen citrate | Tablet | 30.34 mg | Current | Limited Availability | Manufacturing | 15/04/2025 |
deferasirox | Tablet, film coated | 90 mg | Anticipated | Available | Manufacturing | 15/04/2025 |
rivaroxaban | Tablet, film coated | 10 mg | Resolved | Available | Manufacturing | 15/04/2025 |
podophyllotoxin | Solution | 5 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Manufacturing | 15/04/2025 |
deferasirox | Tablet, film coated | 360 mg | Resolved | Available | Manufacturing | 15/04/2025 |
azithromycin dihydrate | Tablet, film coated | 524 mg | Resolved | Available | Unexpected increase in consumer demand | 15/04/2025 |
ketamine hydrochloride | Injection, solution | 115.3 mg/mL | Resolved | Available | Manufacturing | 15/04/2025 |
dydrogesterone~estradiol | Tablet, film coated | 10 mg~2 mg | Current | Limited Availability | Manufacturing | 15/04/2025 |
alprostadil | Injection, powder for | 20 microgram/mL | Current | Limited Availability | Unexpected increase in consumer demand | 15/04/2025 |
metformin hydrochloride | Tablet, film coated | 500 mg | Current | Unavailable | Manufacturing | 14/04/2025 |
risperidone | Tablet, film coated | 3 mg | Resolved | Available | Manufacturing | 14/04/2025 |
risperidone | Tablet, film coated | 4 mg | Resolved | Available | Manufacturing | 14/04/2025 |
risperidone | Tablet, film coated | 1 mg | Resolved | Available | Manufacturing | 14/04/2025 |
risperidone | Tablet, film coated | .5 mg | Resolved | Available | Manufacturing | 14/04/2025 |
risperidone | Tablet, film coated | 2 mg | Resolved | Available | Manufacturing | 14/04/2025 |
pramipexole dihydrochloride monohydrate | Tablet | .125 mg | Resolved | Available | Manufacturing | 14/04/2025 |
midazolam | Injection, solution | 5 mg | Current | Limited Availability | Manufacturing | 14/04/2025 |
methotrexate | Injection, solution | 100 mg/mL | Current | Unavailable | Manufacturing | 14/04/2025 |
noradrenaline (norepinephrine) acid tartrate monohydrate | Injection, concentrated | 4 mg | Resolved | Available | Manufacturing | 14/04/2025 |
prasugrel | Tablet, film coated | 5 mg | Current | Unavailable | Manufacturing | 14/04/2025 |
sildenafil citrate | Tablet, film coated | 140.48 mg | Current | Limited Availability | Manufacturing | 14/04/2025 |
fentanyl citrate | Injection, solution | 785 microgram | Anticipated | Available | Manufacturing | 14/04/2025 |
flecainide acetate | Tablet, uncoated | 100 mg | Current | Limited Availability | Manufacturing | 14/04/2025 |
propofol | Injection, emulsion | 10 mg/mL | Current | Limited Availability | Manufacturing | 14/04/2025 |
clarithromycin | Tablet, film coated | 250 mg | Resolved | Available | Manufacturing | 14/04/2025 |